by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, For Employers and Workplace Safety & Wellness Professionals, Resources
The Drug Screening Compliance Institute (DSCI) provides a robust blog that tracks the fast-paced changes and issues affecting the employment drug and alcohol screening industry. Illinois-based DSCI is co-founded and led by lawyer William “Bill” Judge, who has more...
by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources
Marijuana is an impairing substance. The user experiences reduced motor coordination, short-term memory loss and altered reaction time, all of which has destructive effects in the workplace. High doses of THC, the active ingredient in the cannabis plant, can cause...
by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, For Employers and Workplace Safety & Wellness Professionals, Resources
Quest Diagnostics works to empower people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, Quest’s diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and...
by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, For Employers and Workplace Safety & Wellness Professionals, Resources, Uncategorized
The U.S. Department of Health and Human Services is proposing to establish scientific and technical guidelines for the inclusion of hair specimens in the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Guidelines). We encourage you to review the...
by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, Resources
Guidance for Transgender Collections Under Direct Supervision (Podcast) by NDASA | The U.S. Department of Health and Human Services has addressed this issue for USCG collections, but federal Department of Transportation has not. What should you do? NDASA has...
by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, Resources
When making entries on a paper CCF, use black or blue ink pen and press firmly. Collector ensures the name and address of the HHS-certified laboratory are on the top of the Federal CCF, and that the Specimen Identification (I.D.) number on the top of the Federal CCF...
by NDASA | Apr 22, 2021 | For Drug Testing Industry Professionals, Resources
Note: This manual went to effect Oct. 1, 2017. It applies to federal agency drug testing programs that come under Executive Order 12564 dated September 15, 1986, section 503 of Public Law 100-71, 5 U.S.C. section 7301 note dated July 11, 1987, and the Department of...
by NDASA | Apr 22, 2021 | For Drug Testing Industry Professionals, Resources
Updated: 3/4/2021 When making entries on a paper CCF, use black or blue ink pen, and press firmly. Collector marks the Urine box above STEP 2. Collector ensures that the name and address of the HHS-certified Instrumented Initial Test Facility (IITF) or HHS-certified...
by NDASA | Apr 22, 2021 | For Drug Testing Industry Professionals, Resources
When can a federally regulated program begin using the 2020 Federal CCF? The Office of Management and Budget (OMB) has approved the use of the 2020 Federal CCF as of August 17, 2020. Additional information is available at www.reginfo.gov (enter the OMB number...
by NDASA | Apr 22, 2021 | For Drug Testing Industry Professionals, Resources
The Federal Drug Testing Custody and Control Form is the document used for drug test ordering, specimen collection processing, and chain of custody documentation for workplace drug testing. Get a look at the 2020 form, the most recent version of the form available,...